Signal active
Organization
Contact Information
Overview
i-Optics pioneers smart and superior eye diagnosis solutions that are affordable, fast and user-friendly for care providers worldwide to serve their patients best. Its innovations include: • Cassini – A first-of-its-kind Corneal Shape Analyzer based on Color LED Technology. Cassini measures the true axis and magnitude of corneal astigmatism and is essential for premium IOL planning. Put an end to unexpected refractive outcomes for your astigmatic cataract patients with Cassini from i-Optics. • EasyScan – A breakthrough, zero-dilation retinal imaging system that uses SLO technology to diagnose retinal diseases including diabetic retinopathy, age-related macular degeneration (AMD) and glaucoma.
About
Biotechnology, Product Design, Health Diagnostics
2007
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
i-Optics headquartered in Europe, operates in the Biotechnology, Product Design, Health Diagnostics sector. The company focuses on Biotechnology and has secured $1.3B in funding across 36 round(s). With a team of 1-10 employees, i-Optics is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - i-Optics, raised $5.8M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
3
3
0
$36.1M
Details
2
i-Optics has raised a total of $36.1M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2013 | Late Stage Venture | 15.1M | ||
2010 | Late Stage Venture | 5.8M |
Investors
i-Optics is funded by 7 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Patrick Krol | - | FUNDING ROUND - Patrick Krol | 15.1M |
Aescap Venture | - | FUNDING ROUND - Aescap Venture | 15.1M |
i-Optics | - | FUNDING ROUND - i-Optics | 15.1M |
IPF Partners | - | FUNDING ROUND - IPF Partners | 15.1M |
Recent Activity
There is no recent news or activity for this profile.